APA (7th ed.) Citation

T, P., S, V., V, S., A, D., K, G., & A, P. (2025). Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings? Ophthalmology and therapy, 14(11), 2623. https://doi.org/10.1007/s40123-025-01233-9

Chicago Style (17th ed.) Citation

T, Peto, Vujosevic S, Sheth V, Downey A, Gibson K, and Pollreisz A. "Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?" Ophthalmology and Therapy 14, no. 11 (2025): 2623. https://doi.org/10.1007/s40123-025-01233-9.

MLA (9th ed.) Citation

T, Peto, et al. "Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?" Ophthalmology and Therapy, vol. 14, no. 11, 2025, p. 2623, https://doi.org/10.1007/s40123-025-01233-9.